Article Details
Retrieved on: 2022-10-12 00:16:37
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
11, 2022 (GLOBE NEWSWIRE) — Ambrx Biopharma Inc., or Ambrx, (NYSE: AMAM), a clinical stage biopharmaceutical company using an expanded genetic code ...
Article found on: newsazi.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here